Evidence map›Paper›PMID 41462261›Full record

ArticleJournal of neuroinflammation2025

NKG2D receptor ligands are cell surface biomarkers for injured murine and human nociceptive sensory neurons.

Shuaiwei Wang, Allison M Barry, Yoon Kyung Lee, Naomi Young, Sang Wook Shim, Xinying Wang, Hyeongcheol Kim, Laura Stirling-Barros, Rafael González-Cano, Michael Costigan and 5 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shuaiwei WangNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0000-0002-1659-8962
Allison M BarryNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0000-0002-6787-6889
Yoon Kyung LeeInterdisciplinary Program in Neuroscience, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0009-0002-7466-8233
Naomi YoungNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0009-0001-6257-7185
Sang Wook ShimDepartment of Brain and Cognitive Sciences, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0009-0001-3326-4673
Xinying WangNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Hyeongcheol KimInnoCORE PRISM-AI Research Group, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0003-4327-2148
Laura Stirling-BarrosMedical Sciences Division, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0009-0004-1453-6743
Rafael González-CanoDepartment of Pharmacology, Faculty of Medicine and Biomedical Research Center (Neurosciences Institute), Biosanitary Research Institute, University of Granada, Granada, 18100, Spain.ORCID http://orcid.org/0000-0002-9657-4521
Michael CostiganThe Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Georgios BaskozosNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0000-0001-9237-5878
Simon RinaldiNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0000-0003-2039-3457
David Lh BennettNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.ORCID http://orcid.org/0000-0002-7996-2696
Seog Bae OhInterdisciplinary Program in Neuroscience, Seoul National University, Seoul, 08826, Republic of Korea. odolbae@snu.ac.kr.ORCID http://orcid.org/0000-0001-7975-6895
Alexander J DaviesNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom. alexander.davies@ndcn.ox.ac.uk.ORCID http://orcid.org/0000-0003-0072-1708

Funding

Medical Research Council MR/P008399/1Medical Research Council MR/T020113/1Medical Research Council MR/V02552X/1National Research Foundation of Korea RS-2023-00264409UK Research and Innovation MR/P008399/1UK Research and Innovation MR/T020113/1UK Research and Innovation MR/V02552X/1Wellcome TrustWellcome Trust 215145/Z/18/ZWellcome Trust 223149/Z/21/Z
6 · The paper itself

Abstract

Nociceptors are primary afferent neurons that sense noxious stimuli. They can be activated by tissue injury as well as the accompanying local immune response. We have shown that following nerve injury in mice, cytotoxic Natural Killer (NK) cells infiltrate the peripheral nerve where they interact with stress-induced ligands of the activating receptor NKG2D (Klrk1). However, the diversity and specificity of NKG2D receptor ligands among sensory neuron subtypes, and translation of this mechanism to human cells, remains unknown. We used dorsal root ganglion (DRG) neurons cultured from C57BL/6J mice of both sexes with fluorescently labelled sensory neuron lines (Scn10a, Mrgprd, Calca, Trpv1, Th, Thy1), as well as human induced pluripotent stem cell-derived (hiPSCd)-sensory neurons after laser ablation, as in vitro models of axonal injury. We assessed the expression of NKG2D ligands by quantitative polymerase chain reaction (PCR) corroborated by publicly available RNA sequencing datasets and validated with single-cell PCR. Recombinant NKG2D receptor proteins were used in live cell-based assays to reveal the subcellular membrane localisation of NKG2D ligands with quantification by semi-automated image analysis. Functional interactions between human NK cells and sensory neurons were confirmed with co-cultures in microfluidic devices. We show that NKG2D ligands are expressed exclusively in unmyelinated DRG neurons after injury. Soluble mouse NKG2D receptors bound to puncta along distal neurites of injured axons enriched predominantly in Mrgprd-expressing non-peptidergic nociceptors. We observed low-level binding of soluble human NKG2D receptors to neurites of hiPSCd sensory neurons that increased after axonal laser ablation. Degeneration of hiPSCd sensory neurites by interleukin (IL-2) primed human NK cells was prevented by an NKG2D blocking antibody. The induction and enrichment of functional NKG2D receptor ligands selectively on pathological nerve fibres could aid the diagnosis of peripheral neuropathy in chronic pain conditions, and sheds new light on the potential role of nociceptive neurons in regulating the local tissue immune microenvironment.

Indexed as

NK Cell Lectin-Like Receptor Subfamily KNociceptorsSensory Receptor CellsAnimalsBiomarkersCells, CulturedFemaleGanglia, SpinalHumansLigandsMaleMiceMice, Inbred C57BLBiomarkersKLRK1 protein, humanKlrk1 protein, mouseLigandsNK Cell Lectin-Like Receptor Subfamily KDorsal root gangliaHuman induced pluripotent stem cellsNatural killer cellsNatural killer group 2DNerve injuryNeuro-immuneNeuropathic painNociceptorsNon-peptidergic sensory neuronsPain biomarkersRetinoic acid early transcriptUL16-like binding protein

Identifiers

PMID41462261
PMCPMC12853809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.